← All companies

DNTH

Dianthus Therapeutics, Inc.

DNTH Nasdaq Pharmaceutical Preparations EDGAR ↗

$106.02

-6.62 -5.88%

Key statistics

from XBRL data in SEC filings

Market cap

$5.80B

Revenue (TTM)

$2.04M

Net income (TTM)

-$174M

EPS (TTM)

$-4.23

P/E ratio

—

Dividend yield

—

Free cash flow

-$129M

Cash

$628M

Total assets

$1.25B

Gross margin

—

52-week range

$18.08 – $114.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jun 12, 2026 8-K Shareholder vote results May 22, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Mar 26, 2026 8-K Entered a material agreement Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Mar 9, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Other events Nov 3, 2025 8-K Entered a material agreement; Results of operations (earnings release); Other events Oct 16, 2025 8-K Entered a material agreement Sep 11, 2025 8-K Regulation FD disclosure; Other events Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results May 22, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Director or officer change Mar 5, 2025 8-K Other events Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure Jun 6, 2024 8-K Director or officer change; Shareholder vote results May 28, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 22, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 8-K Other events Dec 21, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023